Annick D. Van den Abbeele
About
Annick D. Van den Abbeele is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology.
According to data from OpenAlex, Annick D. Van den Abbeele has authored 146 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 56 papers in Radiology, Nuclear Medicine and Imaging and 37 papers in Oncology. Recurrent topics in Annick D. Van den Abbeele's work include Gastrointestinal Tumor Research and Treatment (34 papers), Medical Imaging Techniques and Applications (28 papers) and Sarcoma Diagnosis and Treatment (22 papers). Annick D. Van den Abbeele is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (34 papers), Medical Imaging Techniques and Applications (28 papers) and Sarcoma Diagnosis and Treatment (22 papers). Annick D. Van den Abbeele collaborates with scholars based in United States, Switzerland and South Korea. Annick D. Van den Abbeele's co-authors include George D. Demetri, Nikhil H. Ramaiya, Jyothi P. Jagannathan, Michael C. Heinrich, Christopher L. Corless, Margaret von Mehren, Christopher D.�M. Fletcher, Jonathan A. Fletcher, Mizuki Nishino and Ramsey D. Badawi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.
In The Last Decade
Annick D. Van den Abbeele
143 papers receiving 8.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Annick D. Van den Abbeele United States | 43 | 4.4k | 3.3k | 2.3k | 1.8k | 1.6k | 146 | 8.8k | ||
| Nikhil H. Ramaiya United States | 53 | 5.5k 1.3× | 6.3k 1.9× | 605 0.3× | 2.0k 1.1× | 1.5k 0.9× | 339 | 11.9k | ||
| Ole S. Nielsen Denmark | 38 | 3.5k 0.8× | 2.2k 0.6× | 1.2k 0.5× | 1.2k 0.7× | 555 0.3× | 117 | 6.0k | ||
| A. van Oosterom Belgium | 34 | 4.2k 1.0× | 1.8k 0.6× | 3.1k 1.3× | 1.7k 1.0× | 345 0.2× | 88 | 6.7k | ||
| Peter Hohenberger Germany | 57 | 9.0k 2.1× | 5.1k 1.5× | 4.1k 1.7× | 3.8k 2.1× | 888 0.5× | 369 | 13.8k | ||
| William D. Tap United States | 49 | 5.3k 1.2× | 3.8k 1.2× | 993 0.4× | 1.0k 0.6× | 346 0.2× | 293 | 8.7k | ||
| Saša Dimitrijević United States | 24 | 4.8k 1.1× | 1.7k 0.5× | 4.3k 1.8× | 2.1k 1.2× | 351 0.2× | 49 | 8.4k | ||
| Homer A. Macapinlac United States | 52 | 4.9k 1.1× | 1.9k 0.6× | 794 0.3× | 2.4k 1.4× | 5.0k 3.0× | 199 | 9.9k | ||
| Didier Cupissol France | 36 | 4.4k 1.0× | 4.9k 1.5× | 805 0.3× | 2.5k 1.4× | 289 0.2× | 160 | 8.9k | ||
| Shreyaskumar Patel United States | 63 | 10.9k 2.5× | 6.0k 1.8× | 2.5k 1.1× | 3.5k 2.0× | 603 0.4× | 260 | 14.7k | ||
| Donald A. Podoloff United States | 42 | 3.5k 0.8× | 2.9k 0.9× | 845 0.4× | 2.2k 1.2× | 4.0k 2.4× | 135 | 9.9k |
Countries citing papers authored by Annick D. Van den Abbeele
Since
Specialization
Citations
This map shows the geographic impact of Annick D. Van den Abbeele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick D. Van den Abbeele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick D. Van den Abbeele more than expected).
Fields of papers citing papers by Annick D. Van den Abbeele
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Annick D. Van den Abbeele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick D. Van den Abbeele. The network helps show where Annick D. Van den Abbeele may publish in the future.
Co-authorship network of co-authors of Annick D. Van den Abbeele
This figure shows the co-authorship network connecting the top 25 collaborators of Annick D. Van den Abbeele. A scholar is included among the top collaborators of Annick D. Van den Abbeele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick D. Van den Abbeele. Annick D. Van den Abbeele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mehrtash, Alireza, Erik Ziegler, Bhanusupriya Somarouthu, et al.. (2023). Evaluation of mediastinal lymph node segmentation of heterogeneous CT data with full and weak supervision. Computerized Medical Imaging and Graphics. 111. 102312–102312.
2.
Urban, Trinity, Erik Ziegler, Rob Lewis, et al.. (2017). LesionTracker: Extensible Open-Source Zero-Footprint Web Viewer for Cancer Imaging Research and Clinical Trials. Cancer Research. 77(21). e119–e122.
3.
McIntosh, Lacey, et al.. (2017). Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer. Abdominal Radiology. 42(10). 2513–2520.
4.
Lin, Nancy U., Hao Guo, Jeffrey T. Yap, et al.. (2015). Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003). Journal of Clinical Oncology. 33(24). 2623–2631.
5.
Reardon, David A., Prafulla C. Gokhale, Sarah R. Klein, et al.. (2015). Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model. Cancer Immunology Research. 4(2). 124–135.
6.
Mayer, Ingrid A., Vandana G. Abramson, Steven J. Isakoff, et al.. (2014). Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Journal of Clinical Oncology. 32(12). 1202–1209.
7.
Pyo, Junhee, Kyung Won Kim, Heather A. Jacene, et al.. (2013). End-Therapy Positron Emission Tomography for Treatment Response Assessment in Follicular Lymphoma: A Systematic Review and Meta-analysis. Clinical Cancer Research. 19(23). 6566–6577.
8.
George, Suzanne, Qian Wang, Michael C. Heinrich, et al.. (2012). Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial. Journal of Clinical Oncology. 30(19). 2401–2407.
9.
Halasz, Lia M., Heather A. Jacene, Paul J. Catalano, et al.. (2012). Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma: Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET. International Journal of Radiation Oncology*Biology*Physics. 83(5). e647–e654.
10.
Shinagare, Atul B., Fiona M. Fennessy, Nikhil H. Ramaiya, et al.. (2011). Urothelial Cancers of the Upper Urinary Tract. Journal of Computer Assisted Tomography. 35(2). 217–222.
11.
Souza, Frederico, Fiona M. Fennessy, Qunying Yang, & Annick D. Van den Abbeele. (2010). PET/CT appearance of desmoid tumour of the chest wall. British Journal of Radiology. 83(986). e39–e42.
12.
George, Suzanne, Priscilla Merriam, Robert G. Maki, et al.. (2009). Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas. Journal of Clinical Oncology. 27(19). 3154–3160.
13.
Demetri, George D., Michael C. Heinrich, Jonathan A. Fletcher, et al.. (2009). Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure. Clinical Cancer Research. 15(18). 5902–5909.
14.
Otero, Hansel J., Jyothi P. Jagannathan, Luciano M. Prevedello, et al.. (2009). CT and PET/CT Findings of T-Cell Lymphoma. American Journal of Roentgenology. 193(2). 349–358.
15.
Abbeele, Annick D. Van den, et al.. (2008). Infrequent Tumors of the Gastrointestinal Tract Including Gastrointestinal Stromal Tumor (GIST). PET Clinics. 3(2). 207–215.
16.
Herbst, Roy S., Angela M. Davies, Ronald B. Natale, et al.. (2007). Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 13(20). 6175–6181.
17.
Abbeele, Annick D. Van den, Ramsey D. Badawi, Judith Manola, et al.. (2004). Effects of cessation of imatinib mesylate (IM) therapy in patients (pts) with IM-refractory gastrointestinal stromal tumors (GIST) as visualized by FDG-PET scanning. Journal of Clinical Oncology. 22(14_suppl). 3012–3012.
18.
Heinrich, Michael C., Christopher L. Corless, George D. Demetri, et al.. (2003). Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 21(23). 4342–4349.
19.
Tumeh, Sabah S., et al.. (1991). Detection of focal infection by 111In-human polyclonal IgG.. PubMed. 35(1). 4–9.
20.
Baranowska‐Kortylewicz, Janina, G. Mike Makrigiorgos, Annick D. Van den Abbeele, et al.. (1991). 5-[123I]iodo-2′-deoxyuridine in the radiotherapy of an early ascites tumor model. International Journal of Radiation Oncology*Biology*Physics. 21(6). 1541–1551.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nikhil H. Ramaiya Breakdown of academic impact, for papers by Ole S. Nielsen Breakdown of academic impact, for papers by A. van Oosterom Breakdown of academic impact, for papers by Peter Hohenberger Breakdown of academic impact, for papers by William D. Tap Breakdown of academic impact, for papers by Saša Dimitrijević Breakdown of academic impact, for papers by Homer A. Macapinlac Breakdown of academic impact, for papers by Didier Cupissol Breakdown of academic impact, for papers by Shreyaskumar Patel Breakdown of academic impact, for papers by Donald A. Podoloff